The latest After 2½ years of studies of a virus that has killed 6.5 million people globally, coronavirus enigmas still plague scientists and the public. My colleague Mark Johnson recently explored some of the most pressing questions such as "where did the virus come from, and why has it been so successful?" and "why do some people develop long covid?" in his latest piece. The complexities of the virus have led researchers to publish more than 200,000 studies, which is four times more than the number of research papers written on the flu in the past century, Johnson reports. The U.S. government has spent almost $4 trillion in its response to the pandemic. New research shows that transplant patients treated with immunosuppressive drugs later tested positive for a coronavirus variant that is resistant to treatment. According to findings from researchers at the NYU Grossman School of Medicine and NYU Long Island School of Medicine, two kidney transplant patients were treated with remdesivir after developing covid-19. They were readmitted to the hospital after developing symptoms including fatigue, cough and a fever, despite being vaccinated. When doctors tested the patients, they identified a gene mutation that wasn't previously present and appeared only after the patients took the antiviral treatment. The mutation made the virus more resistant to remdesivir. Remdesivir — developed initially to treat hepatitis C — is one of the few antiviral therapies approved by the Food and Drug Administration to treat hospitalized coronavirus patients. "In the future, physicians might also screen for such mutations before making treatment decisions for their most vulnerable patients," Adriana Heguy, one of the study authors, said in a statement. Other important news In recent weeks, many of our loyal readers have asked for Coronavirus Updates to include coverage of other important health issues, such as monkeypox and the flu. And we want to let you know that we're listening and incorporating additional information on other viruses into this newsletter. Additionally, if there are other health topics you would like to see us cover, please send a note to Sabrina.Malhi@washpost.com. Monkeypox cases are declining nationwide. Experts are cautiously optimistic but are "bracing for monkeypox to stick around as a background threat with periodic flare-ups," my colleagues Fenit Nirappil and Lena H. Sun report. They explore some of the most commonly asked questions surrounding the virus. All major cruise lines will drop their vaccine requirements. On Oct. 14, Disney Wish, Disney Dream, Disney Fantasy and Disney Wonder won't require the shot, but it's still "highly recommended," The Post's James Bikales reports. |
No comments:
Post a Comment